Objective: The aim of this study was to determine whether selective activation of the adenosine A receptor reduces infarct size in a 3
elicited a concentration-dependent reduction in infarct size; 50 nM IB-MECA reduced IArAAR to 24 " 4%. The A -selective agonist, 1 Ž . Ž . R-PIA 25 nM reduced IArAAR to a similar extent 21 " 6% . However, while the cardioprotective effect of R-PIA was significantly Ž . Ž . inhibited 54 " 7% IArAAR by the rabbit A -selective antagonist, BWA1433 50 nM , the IB-MECA-dependent cardioprotection was 1 Ž . Ž . Ž . unaffected 28 " 6% IArAAR . A non-selective A vs. A concentration of BWA1433 5 mM significantly attenuated the
Introduction w x
Ischemic preconditioning 1 refers to a phenomenon in which a brief ischemic event protects the myocardium from a subsequent prolonged ischemic insult. Numerous humoral agents have been proposed to either mediate or mimic ischemic preconditioning, but a significant portion of the attention has focused on adenosine and its analogues. The ability of adenosine to provide cardioprotection from ischemic injury was first proposed by Ely et al. w x 2 , while subsequent studies by Downey and colleagues w x w x 3-6 and others 7-9 indicated adenosine's cardioprotec- The putative role of the A receptor in mediating 3 adenosine-dependent cardioprotection is based primarily w x on recent studies performed in the rabbit 5,7 . In these Ž . studies however, a non-selective A rA adenosine re-1 3 Ž 6 Ž . ceptor agonist APNEA, N -2-4-aminophenyl ethyl-. adenosine was used in the presence of mixed A rA and 1 3 Ž olated from rat and sheep receptor binding data since data . for the rabbit A and A receptors were not available . We have recently cloned, expressed and pharmacologically characterized the rabbit adenosine A and A recep-1 3 w x tors 10 . IB-MECA was identified as a modestly selective w x rabbit A receptor agonist 10 and provided the opportu-3 nity to investigate for the first time the ability of selective A receptor activation to elicit cardioprotection without 3 the confounding influence of A receptor stimulation. We 1 now report that IB-MECA is able to selectively stimulate adenosine A receptors in the isolated rabbit heart, and 3 that activation of A receptors does indeed provide cardio-3 protection in this model, thus corroborating previous studies which indirectly demonstrated this effect. These data also demonstrate that A receptor stimulation provides a 3 degree of cardioprotection similar to that elicited by A 1 receptor stimulation or ischemic preconditioning. . was performed, the heart exposed, and a snare 2-0 silk placed loosely around a branch of the left coronary artery. The heart was rapidly removed from the chest, mounted on a Langendorff apparatus, and maintained by retrograde Ž . perfusion non-recirculating with a modified Krebs solu-Ž tion NaCl 118.5 mM, KCl 4.7 mM, MgSO 1.2 mM, 4 KH PO 1.2 mM, NaHCO 24.8 mM, CaCl 2.5 mM, 2 4 3 2 . and glucose 10 mM at a constant pressure of 80 mm Hg and a temperature of 378C. Perfusate pH was maintained at 7.4-7.5 by bubbling with 95% O r5% CO . The tempera-2 2 ture of the hearts was maintained by suspending them in heated, water-jacketed organ baths. A fluid-filled latex balloon was inserted in the left ventricle and connected by stainless steel tubing to a pressure transducer; the balloon was inflated to provide a systolic pressure of 80-120 mm Ž . Hg, and a diastolic pressure F 10 mm Hg. Heart rate HR and left ventricular diastolic and systolic pressures were recorded using a PO-NE-MAH Data Acquisition and Ž . Archive System Simsbury, CT ; left ventricular developed Ž . pressures LVDP were calculated by subtracting the left ventricular diastolic pressure from the left ventricular sys-Ž . tolic pressure. Total coronary flows CF were determined by timed collection of coronary effluent and measuring the fluid volume; all coronary flows were normalized for heart weight.
Methods

Experimental model
Hearts were allowed to equilibrate for 30 min; if stable left ventricular pressures within the parameters outlined above were not observed, the heart was discarded. Hearts were not paced, unless the heart rate fell below 180 bpm prior to the 30 min period of regional ischemia; in this case, the heart was paced at 200 bpm, which was the Ž . Fig. 1 . Experimental protocol. A Hearts were subjected to either 5 min of global ischemia or 5 min of perfusion with an adenosine receptor agonist Ž . Ž . R-PIA or IB-MECA . This was followed by 30 min of regional ischemia and 120 min of reperfusion. B When an adenosine receptor antagonist Ž . BWA1433 was used, it was perfused through the heart for 15 min, either alone or in combination with a 5 min perfusion period of either R-PIA or IB-MECA. This was followed by 30 min of regional ischemia and 120 min of reperfusion. 
Ischemic preconditioning
Ischemic preconditioning was attained by total cessation Ž of cardiac perfusion global ischemia; cross-clamping of . the aortic perfusion line for 5 min, followed by reperfu-Ž . sion for 10 min Fig. 1A . A subsequent 30 min period of regional ischemia was produced by tightening the snare around the branch of the coronary artery. At the end of this period, the snare was released and the heart reperfused for an additional 120 min.
Pharmacological preconditioning
Pharmacological studies were based on rabbit A and 1 w x A receptor affinity data generated by Hill et al. 10 3 Ž . Ž Table 1 . Using these data, drug concentrations ) 10-fold . higher than the A or A receptor K were specifically or the A -selective agonist, R-PIA, were perfused through 1 the heart for 5 min, followed by a 10 min wash-out before the 30 min regional ischemia-120 min reperfusion period Ž . Fig. 1A . In experiments using the A -selective antago-1 nist, BWA1433, the drug was perfused through the heart for a total of 15 min, beginning 5 min before the agonist perfusion period, continuing through the agonist perfusion and ending 5 min after the agonist perfusion was stopped Ž . Fig. 1B . A 5 min wash-out period followed before the ischemia-reperfusion periods.
Determination of infarct size
At the end of the 120 min reperfusion period, the coronary artery snare was tightened and a 0.5% suspension Ž . of fluorescent zinc cadmium sulfate particles 1-10 mM was perfused through the heart to delineate the area-at-risk Ž . non-stained for infarct development. The heart was removed from the Langendorff apparatus, blotted dry, weighed, wrapped in aluminum foil and stored overnight at y208C. Frozen hearts were sliced into 2 mm transverse sections from the apex to just above the coronary artery snare. The slices were incubated with 1% triphenyl tetrazolium chloride in phosphate-buffered saline for 20 min at Ž . 378C to delineate non-infarcted stained from infarcted Ž . non-stained tissue. The infarct area and the area-at-risk were calculated for each slice of left ventricle using a Ž precalibrated image analyzer Optomax V Image Analyzer, . AMS, Burlington, MA , followed by adding the values for each tissue slice to obtain the total infarct area and total area at risk for each heart. To normalize the infarct area for differences in the area-at-risk between hearts, the infarct size was expressed as the ratio of infarct area vs. area-at-Ž . risk % IArAAR .
Data expression and analysis
Data are expressed as the mean " s.e. Comparisons of hemodynamic variables were performed by paired t test, while group % IArAAR values were compared using a Ischemic preconditioning 7 212"6 5.6"0.6 90"3 216"6 3.9"0.5 61"6 ) )
25 nM R-PIA 6 206"10 5.8"0. Mann-Whitney test with a Bonferroni correction for multiple comparisons. A P value of less than 0.05 was considered statistically significant.
Drugs and drug preparation
Ž . 6 Ž . The drugs used were R y -N -2-phenylisopropyl -Ž . 6 Ž adenosine R-PIA; purchased from RBI , N -3-iodoben-.
X Ž zyl adenosine-5 -N-methyluronamide IB-MECA; synthe-. Ž . sized by Pfizer , and 8-4-carboxyethenylphenyl -1,3-di-Ž . propylxanthine BWA1433; synthesized by Pfizer . R-PIA was dissolved in buffer, while IB-MECA and BWA1433 were dissolved in DMSO and diluted in buffer; the final DMSO concentration was less than 0.1%, which had no Ž Ž . effect on infarct size control n s 7 : 67"5% IArAAR Ž . . vs. DMSO n s 7 : 64"7% IArAAR; P ) 0.05 .
Results
Baseline heart rate, coronary flow and left ventricular developed pressure values for each of the treatment groups were similar prior to the regional ischemia and are shown in Table 2 . Coronary flow and left ventricular developed Ž . pressure were both significantly P -0.05 reduced by occlusion of the coronary artery in all groups, confirming that ischemia was achieved even in those groups in which Fig. 2 . Effect of ischemic preconditioning, R-PIA, and R-PIAqBWA1433 on % IArAAR in isolated rabbit hearts. Ischemic preconditioning was produced by a 5 min period of global ischemia followed by 10 min of reperfusion. R-PIA or BWA1433 were perfused through the hearts for 5 or 15 min, respectively, as described in Section 2. After ischemic preconditioning or drug administration, hearts were subjected to 30 min of regional ischemia, followed by 120 min of reperfusion. Infarct areas and area-at-risk were determined by image analysis and infarct area was Ž . normalized for area-at-risk % IArAAR . Data from each heart are presented, along with the mean"s.e. for each group. ns6-8; ), signifi-Ž . Ž cantly different P -0.05 from control; †, significantly different P -. 0.05 from 25 nM R-PIA. Fig. 3 . Effect of IB-MECA on % IArAAR in isolated rabbit hearts and of BWA1433 on IB-MECA-dependent cardioprotection. IB-MECA or BWA1433 were perfused through the hearts for 5 or 15 min, respectively, as described in Section 2. After drug administration, hearts were subjected to 30 min of regional ischemia, followed by 120 min of reperfusion. Infarct areas and area-at-risk were determined by image analysis and Ž . infarct area was normalized for area-at-risk % IArAAR . Data from each heart are presented, along with the mean"s.e. for each group. ns6-11; Ž . ) , significantly different P -0.05 from control; †, significantly differ-Ž . ent P -0.05 from 50 nM IB-MECA.
infarct size was significantly reduced. Area-at-risk expressed as a percent of left ventricular area was 44 " 6% Ž . ns7 for the control group; other groups did not differ Ž . significantly P G 0.05 from the control group.
Ischemic preconditioning significantly reduced infarct Ž size in the isolated rabbit hearts by 72% 19 " 4% . Ž IArAAR compared to non-preconditioned controls 67 " . Ž . 5% IArAAR Fig. 2 . The A -selective agonist, R-PIA 1 Ž . Ž . 25 nM reduced infarct size by 69% 21 " 6% IArAAR , which was similar to that provided by ischemic precondi-Ž . tioning Fig. 2 . Furthermore, an A -selective concentra- mediating the cardioprotection afforded by either ischemic preconditioning or adenosine analogues in the isolated w x w x heart 5 or cardiomyocytes 7 from the rabbit. However, the contribution of A receptor activation to cardioprotec-3 tion was determined in an indirect manner using a 'subtractional pharmacology' approach, i.e., a non-selective Ž . Ž . A r A adenosine receptor agonist APNEA was evalu- activation. In addition, the authors were necessarily forced to rely on the affinities and selectivities of adenosine receptor ligands for cloned rat and sheep receptors, since these data were not available for the rabbit A and A 1 3 receptors at the time. We recently found the pharmacology of the rabbit adenosine receptors differs from that of other species and identified IB-MECA as a selective agonist for Ž . w x the rabbit A receptor 15-fold vs. the A receptor 10 . This allowed us for the first time to directly, i.e., selectively, investigate the role of the A receptor in cardiopro-3 tection.
In the present study, we observed that IB-MECA elicited a concentration-dependent reduction in infarct size in the isolated rabbit hearts. Since the concentration of IB-MECA Ž . 10 nM which produced a nearly maximal reduction in infarct size was 3-fold lower than the K for the rabbit A . tive agonist, R-PIA , did not reduce the maximum IB-MECA-dependent cardioprotection, providing further confirmation that the cardioprotective effects of IB-MECA were A receptor-mediated. A higher, non-A -selective
